May 2011 Briefing - UrologyLast Updated: June 01, 2011.
Here are what the editors at HealthDay consider to be the most important developments in Urology for May 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Effect Estimates May Be Inflated in Biomarker Studies
TUESDAY, May 31 (HealthDay News) -- Biomarker effects are often overestimated in highly cited studies compared to the effects reported in subsequent meta-analyses of the same associations, according to a review published in the June 1 issue of the Journal of the American Medical Association.
BoNT-A Alleviates Neurogenic Detrusor Overactivity
FRIDAY, May 27 (HealthDay News) -- OnabotulinumtoxinA (BoNT-A) intradetrusor injection may be clinically beneficial and is well tolerated by adults with neurogenic detrusor overactivity (NDO) and antimuscarinic-refractory incontinence, according to a study published in the June issue of The Journal of Urology.
Surgical Delay Associated With Worse Prostatectomy Outcome
THURSDAY, May 26 (HealthDay News) -- Delaying radical prostatectomy by six months or more in men who meet the D'Amico low-risk criteria for prostate cancer is correlated with worse outcomes, according to a study published in the June issue of The Journal of Urology.
Abiraterone Tied to Metastatic Prostate Cancer Survival
WEDNESDAY, May 25 (HealthDay News) -- Abiraterone acetate prolongs overall survival among patients with metastatic castration-resistant prostate cancer who have received chemotherapy, according to a study published in the May 26 issue of the New England Journal of Medicine.
Contact With Drug Industry Linked to Positive Attitudes
WEDNESDAY, May 25 (HealthDay News) -- The extent of contact that medical students have with the pharmaceutical industry is associated with positive attitudes about marketing, according to a review published online May 24 in PLoS Medicine.
Brisk Walking May Lower Prostate CA Progression Risk
WEDNESDAY, May 25 (HealthDay News) -- Brisk walking may help slow disease progression in men diagnosed with clinically localized prostate cancer, according to a study published online May 24 in Cancer Research.
Heart-Friendly Fatty Acids Linked to Prostate Cancer
TUESDAY, May 24 (HealthDay News) -- High levels of the ω-3 fatty acid docosahexaenoic acid may increase the risk of high-grade prostate cancer; whereas, high levels of trans-fatty acids (TFAs) may reduce the risk, according to a study published online April 24 in the American Journal of Epidemiology.
Erectile Dysfunction Linked to Diabetic Retinopathy
TUESDAY, May 24 (HealthDay News) -- Significant erectile dysfunction (ED) is associated with diabetic retinopathy (DR) severity, independent of age, diabetes duration, macrovascular comorbidities, and cardiovascular risk factors, according to a study published in the May issue of Urology.
Inhaled Anticholinergics Tied to Acute Urinary Retention
TUESDAY, May 24 (HealthDay News) -- Men with chronic obstructive pulmonary disease (COPD) using both short- and long-acting inhaled anticholinergic (IAC) drugs have an increased risk of developing acute urinary retention (AUR), according to a study published in the May 23 issue of the Archives of Internal Medicine.
Many Medical Students Lack Confidence in Medical Law
FRIDAY, May 20 (HealthDay News) -- The majority of medical students lack confidence in their knowledge and skills across many areas of medical law, according to a study published online May 16 in the Journal of Medical Ethics.
Limiting Gadolinium Use May Avert Renal Systemic Fibrosis
FRIDAY, May 20 (HealthDay News) -- Following the adoption of restrictive guidelines for gadolinium-based contrast agent (GBCA) administration, no new nephrogenic systemic fibrosis (NSF) cases have been identified in contrast-enhanced magnetic resonance (MR) examinations, even in patients with a low estimated glomerular filtration rate (eGFR), according to a study published online May 17 in Radiology.
Family Cancer Histories Are Not Highly Accurate
WEDNESDAY, May 18 (HealthDay News) -- General population reports on family history for major adult cancers are not very accurate, according to a study published online May 11 in the Journal of the National Cancer Institute.
High Coffee Intake May Reduce Prostate Cancer Risk
WEDNESDAY, May 18 (HealthDay News) -- The risk of advanced or lethal prostate cancer is lower in men who regularly consume coffee, according to a study published online May 17 in the Journal of the National Cancer Institute.
Anogenital Distance Shorter in Infertile Men
TUESDAY, May 17 (HealthDay News) -- Shorter anogenital distance (AGD) appears to be associated with infertility in men, according to research published online May 11 in PLoS One.
Surgical Catheter Complications Affect Health Outcomes
MONDAY, May 16 (HealthDay News) -- Catheter-related complications for surgical procedures are relatively uncommon, but they are correlated with an increased length of stay and urinary tract infections, according to a study published in the May issue of The Journal of Urology.
Medical Education Participants Recognize Funding Bias
WEDNESDAY, May 11 (HealthDay News) -- Although most medical professionals believe that commercial funding of continuing medical education (CME) introduces bias, most are not willing to pay higher fees to offset or eliminate such funding sources, according to a study published in the May 9 issue of the Archives of Internal Medicine.
Radical Prostatectomy Beats Watchful Waiting at 15 Years
WEDNESDAY, May 4 (HealthDay News) -- After 15 years, radical prostatectomy appears to be associated with a reduction in the rate of death from prostate cancer as compared to watchful waiting, according to a study published in the May 5 issue of the New England Journal of Medicine.
Low Urinary Sodium Excretion Linked to Higher Mortality
WEDNESDAY, May 4 (HealthDay News) -- Lower sodium excretion is associated with an increased risk of cardiovascular disease (CVD) mortality, according to a study published in the May 4 issue of the Journal of the American Medical Association.
Efficacy of Stereotactic Body Radiation Therapy Unclear
TUESDAY, May 3 (HealthDay News) -- Though stereotactic body radiation therapy (SBRT) is currently used as a treatment for various solid malignant tumors, there is a lack of evidence confirming its effectiveness and safety, according to a review published online May 2 in the Annals of Internal Medicine.
Acupuncture Found to Relieve Hot Flashes in Men
MONDAY, May 2 (HealthDay News) -- Acupuncture appears to be quite effective at relieving the hot flashes that are a common side effect of androgen ablation therapy (AAT) in men with prostate cancer, according to research published in the April 1 issue of the International Journal of Radiation Oncology*Biology*Physics.
|Previous: May 2011 Briefing - Surgery||Next: May 2011 Briefing - Internal Medicine|
Reader comments on this article are listed below. Review our comments policy.